Abstract. The oncogenic potential of hepatitis C virus (HCV) core protein has been demonstrated, but the precise mechanism of cell transformation triggered by HCV core is still unclear. This study shows that constitutive expression of HCV core protein (core) in NIH 3T3 murine fibroblasts triggers malignant transformation. At the preneoplastic stage, clones that expressed HCV core constitutively demonstrated genomic instability seen as disruption of the mitotic spindle cell checkpoint leading to increased ploidy. Transformation was completed by the loss of DNA and resistance to apoptosis induced by serum starvation. Simultaneously, cells acquired a capacity for anchorage independent growth and absence of contact inhibition. Inoculation of these transformed cells into severe combined immune deficiency (SCID) mice led to formation of solid core-expressing tumors. Transformation and tumorigenicity of core-expressing cell lines coincided with a 5-to 10-fold repression of endogenous p53 transactivation. Thus, long-term HCV core expression alone is sufficient for complete transformation of immortal fibroblasts that can then induce tumors in a susceptible host. This data suggests that malignant transformation by HCV core may occur through primary stress, induction of genomic instability, and further HCV core-induced rescue of surviving mutated cells.
Introduction
Hepatitis C virus (HCV) is a positive strand RNA virus that belongs to the Hepaciviridae genus within the Flaviviridae family. HCV infection has a wide spectrum of clinical presentations; 55% to 85% of patients do not clear virus, but develop chronic hepatitis C [14] . The chronic sequelae of hepatitis C include progressive hepatic fibrosis and cirrhosis, the major risk factors of hepatocellular carcinoma (HCC), and eventually HCC [17] . It is becoming increasingly evident that HCV not only causes cell renewal coupled with inflammation that indirectly triggers HCC, but is directly involved in hepatocarcinogenesis [17, 27, 49] . One of the suspected inducers of HCV-related HCC is the nucleocapsid (core) protein [27] . It has versatile effects on the host cells by direct/indirect regulation of various promoters and modulation of apoptosis [27, 58] . By transmitting growth stimuli and interfering with intracellular signal transduction, HCV core can immortalize, and in collaboration with onco-genes, transform mammalian cells [46] . In vivo, progression to tumors is often driven by growth constraint of the host tissue associated with stress conditions [30] . Transiently expressed HCV core exerts a multitude of stresses, such as an oxidative stress with mitochondrial injury [31, 37, 41] , and NF-kappa B activationdependent endoplasmic reticulum (ER) stress mediated by the ER-overload [24] . As an in vivo implication, mice transgenic for HCV core gene often develop malignant lymphomas, hepatocellular carcinomas and adenomas [20, 27] .
Part of the oncogenic potential HCV core protein gains through affecting activities of the tumor suppressor protein TP53 (p53). In transiently transfected cells, HCV core augments p53 DNA-binding and transactivation. This leads to the cell growth arrest at the G1 phase of the cell cycle or induction of apoptosis [33, 42] . Indirect p53 activation through core-induced upregulation of cellular proto-oncogenes [44] could also play a role. Besides, HCV core modulates the activity of p53 transcriptional targets, such as cyclin kinase inhibitor p21 [29, 33, 39, 62] . An increase in p21 expression acts as a stress factor by decreasing percentage of cells in the S-phase along with accumulation of cells in the G0/G1 phase [39] .
Controversial data exist on the effects of HCV core in the constitutively expressing cell lines. The activity of p53 and the transcriptional targets of p53, p21 and the 14-3-3 family, appears to be suppressed [1, 29, 46, 62] . In addition, core expression ( 72 h) induces up-regulation of cyclins E1 and D1 [6, 64] , decreases the Rb levels and up-regulates E2F-1, disrupting the performance of the pRB-E2F-1 complex as transcriptional repressor [7] . These HCV core activities allow for p53-uncontrolled rapid cell proliferation. Unlimited cell growth is further promoted by HCV core binding to the intracellular signal-transducing portion of death receptors that displaces signalling molecules and interferes with apoptosis [28, 58] . Thus, HCV core effects eukaryotic cells in a biphasic fashion, first by inducing multiparametric stress, and then by releasing stress and promoting growth of the surviving cells.
With this in mind, we have studied the genomic surveillance mechanisms reflected by growth, ploidy, sensitivity to apoptosis, and p53 transactivation during the establishment of NIH 3T3 cells that express core constitutively, and finalised this with in vivo assessment of their tumorigenic potential.
Materials and methods

Plasmids
Plasmid pCMVcore191 carrying gene for HCV core aa 1-191 (AF176573) under the control of CMV IE promoter was described earlier [18] . Neomycinresistance gene (Neo r ) was amplified from pRC-CMV (Invitrogene, Carlsbad, CA) and inserted into pCMVcore191 to generate pCMVcore191Neo r . Plasmid pCMVNS3Neo r encoding ATPase/helicase (NS3) of HCV 274933RU and Neo r was constructed likewisely from pCMVNS3 described previously [19] . Control pCMVNeo r was a pUC8-based vector with the Neo r -coding cassette, and CMV IE promoter. Plasmid pCMVcore152 encoding C-terminus truncated version of HCV core aa 1-152 was described earlier [18] . Reporter plasmid pG13-luc carrying 13 repeats of the consensus wild-type p53 binding sequence was kindly provided by Dr WS El-Deiry [11] . Plasmid pSVβ-gal expressing β-galactosidase was purchased (Promega, Madison, WI).
Cells
NIH 3T3 was maintained in DMEM (Life Technologies, Inc., Gaithersburg, MD) supplemented with 10% fetal calf serum (FCS; Life Technologies). To avoid spontaneous transformation, cells were not allowed to reach confluency, and were re-plated 1 : 5 every three days. Cells were transfected/co-transfected with plasmids using LipofectAMINE TM (Life Technologies), and in transient transfections, harvested after 48 h. To create cell lines of NIH191 series, NIH 3T3 were transfected with pCMVcore191Neo r ; and for NIHNS series, with pCMVNSNeo r . Control NIH 3T3 cells were transfected with pCMVNeo r alone. Clones were selected on G418-containing medium (40 µg/ml) as was described [52] .
Mice
Female, 10 weeks old, C.B-17/SCID mice [2] were bred under pathogen-free conditions and maintained at the animal facility of the Swedish Institute for Infectious Disease Control, Sweden.
Immune stainings
Western blotting was done with primary anti-HCV core- [18] or NS3- [19] antibodies, peroxidase-conjugated secondary antibodies (DAKOPatts AB, Copenhagen, Denmark) using chemiluminiscence detection system (ECL kit; Amersham-Pharmacia Biotech, Piscataway, NJ) as was described [18, 19] .
Cell proliferation assays
To determine the doubling time, cells were seeded in 35 mm dishes at a density of 2 × 10 4 cells/dish. Cells were fed DMEM with 10% FCS every day, the number of cells from duplicate plates were counted manually with a hemocytometer every other day. The doubling time was determined from the growth curve. The saturation density was determined as the number of cells at confluence divided by the dish area. To estimate plating efficiencies, 200-400 cells were seeded in 50-mm dishes containing 10 ml of DMEM supplemented with 10% FCS. Cells formed colonies within 2 weeks, plates were then stained with 0.1% Crystal Violet in 25% ethanol. Colonies with more than 50 cells were scored.
Anchorage-independent growth assay
Soft agar dishes (50 mm) were prepared with an underlayer of 0.5% agar (Difco, Detroit, MI, USA) in DMEM containing 10% FCS. Cells were seeded in the dishes in DMEM containing 10% FCS and 0.33% agar at a density of 4 × 10 3 cells/dish. Colonies that developed in the agar suspension 2 weeks after seeding, were counted and photographed using phase-contrast photomicrography; those with >200 cells ( 0.1 mm in diameter) were scored. Results were expressed as % of colonies formed per total number of seeded cells. Each experiment was performed in triplicate.
Flow cytometry
Cells were harvested, washed in PBS, permeabilized with 0.1% saponin for 0.5 h, washed in PBS, stained with a solution containing propidium iodide (50 µg/ml) and RNase (2 U/ml), and analysed on ODAM ATC-3000 flow sorter-analyser (Bruker Spectrospin, Wissembourg, France) by one-parameter FACScanning. The analysis rate was 400-600 cells/sec. A total of 15 000-20 000 cells were analysed in each sample. For serum starvation, cells in exponential growth phase (60-80% confluence) were rinsed with PBS, and cultured in DMEM with 0.5% FCS for up to 9 days. For G2/M arrest, cells at 70% confluence were treated with nocodazole (200 ng/ml; Sigma) for 24 h. Ploidy was assessed using diploid mouse splenocytes as an internal standard. Clones were assessed in three independent runs. Data was processed using ModFit 2.0 software (Verity Software House Inc., Topsham, ME).
Reporter gene assays
NIH 3T3 were co-transfected with reporter plasmids pG13-luc and pSVβ-gal, or with reporter plasmids and either pCMVcore191, or pCMVcore152. NIH191 cell lines were co-transfected with pG13-luc and pSVβ-gal. After 48 h, cells were lysed with Luciferase Cell Culture Lysis Buffer (Promega, Madison, WI). Soluble proteins were recovered and quantified using Bradford assay (BioRad, Hercules, CA). Luciferase activity in soluble fractions was measured using Luciferase Assay System (Promega), and β-galactosidase activity, using ortho-nitrophenyl-galactopyranoside (4 mg/ml; Sigma). The p53-dependent transactivation was represented as a mean ratio of luciferase to β-galactosidase activity in three independent experiments.
Tumorigenicity
NIH191-3, NIH191-10, or NIHNS clones were cultured to 70% confluency, harvested using 0.001% trypsin and 0.02% EDTA for 5 min at 37 • C, washed once in DMEM with 2% FCS and once with PBS, and re-suspended in PBS. Age-matched groups of C.B-17/SCID mice (3-4/group) were inoculated subcutaneously in the abdomen with 2 × 10 4 , or 2 × 10 5 , or 2 × 10 6 of NIH191-3, or NIH191-10, or NIHNS cells suspended in 100 µl PBS, or sham-inoculated with PBS. Tumors were monitored by palpating at 2-day intervals, and measured with the Vernier calipers. When first tumors reached 10 mm in diameter, all mice were anethized, and sacrificed. Tumors were removed and evaluated as was described [26] . Half of each of the excised tumors was frozen at −70 • C, and half was formalin-fixed and paraffin-imbedded. Frozen tissues and paraffin blocks were cut into 7-9 µm sections, and fixed. Paraffin sections were routinely stained with hematoxylin and eosin (H&E). Frozen sections were stained with anti-HCV core [18] , or control antibodies as was described earlier [43] .
Results
HCV core-gene expression in NIH 3T3 transfectants
We established cell lines that expressed HCV core constitutively as judged by specific immunofluorescence staining and Western blot done using previously described core-specific rabbit polyclonal serum [18] ( Fig. 1) . Western blotting demonstrated expression of proteins with the molecular mass of approximately 21 and 19 kDa (Fig. 1C) , the shorter form appearing as a result of the earlier shown processing of the full-length HCV core [29, 39] . Immunofluorescence analysis revealed strong perinuclear granular staining and a weaker nuclear staining (Fig. 1A ,B). Double staining was consistent with the coexistence of two forms, the full length localizing in the cytoplasm, and the processed localizing in the nucleus [32] . Corespecific rabbit serum did not stain the control HCV NS3-expressing NIH 3T3 cell line, and NIH191-3 and NIH191-10 cells were not stained with sera collected from the rabbit prior to core immunization (data not shown).
Growth properties and morphology of HCV core gene-transfected NIH 3T3
Phenotypic changes in the HCV core gene-transfected cells were observed already at the early passages. Transfected cells had numerous flattened giant cells (but no multinucleated giant cells), and did not reach confluency even after one week. Expression of core protein led to an increase in the mean doubling time and a decrease in the saturation density (Table 1) . Colony formation efficiency assays demonstrated a substantial reduction in the number of colonies as compared to the control NIH 3T3 and NIH 3T3 Neo r cells (Table 1) . After approximately 50 passages, the phenotype of the surviving clones (c.a. 30%) has changed. Giant cells disappeared. Doubling time decreased, while saturation density and colony formation efficiency were restored to the NIH 3T3 levels (Table 1) . Simultaneously, cells acquired focus-forming morphology (data not shown). Clones formed significant numbers of colonies in soft-agar medium, strongly indicating the transformed phenotype (Fig. 2) . These characteristics were retained even after re-populations at low density done to eliminate core expressing, but non-transformed sub-clones. No morphological changes were observed in the iden- Note. Points are means of at least three independent experiments; errors are the standard errors of the mean (SEM). tically treated NIH3T3 cells transfected with Neo rvector alone. Two typical clones, one with a lower, and one with a higher level of core expression, designated NIH191-3 and NIH191-10 ( Fig. 1) were taken into a further study.
Suppression of serum starvation-induced cell death
We next analysed the effect of stable core expression on the sensitivity of cells to apoptosis induced by serum starvation. In concordance with the data for the in vitro cultured skin fibroblasts [65] , cells starved for 1 day showed no significant increase in apoptosis (data not shown). After 3-4 days of starvation, NIH 3T3 Neo r clones began to die exhibiting extensive cell rounding, shrinkage, cytoplasmic blabbing, and chromatin condensation, while core-expressing cells remained alive (Fig. 3) . After 6 days, the percentage of apoptotic cells with fragmented/apoptotic DNA (<2N) was 31% in NIH 3T3 Neo r , 2.5% in NIH191-3, and 7% in NIH191-10 clones (Fig. 2) . 
Activity of mitotic spindle cell cycle checkpoint
The activity of the mitotic spindle cell cycle checkpoint during transformation was analysed by flow cytometry. At the preneoplastic stage, FACS analysis of NIH191-3 and NIH191-10 clones revealed three peaks with DNA content 2N, 4N and 8N; all cells with DNA content of over 4N were accounted for as "tetraploids" (Fig. 4, panel I ). Since G2/M diploids and G0/G1 tetraploids cannot be distinguished (both 4N), we synchronised both in the G0/G1 phase by serum deprivation, and thus estimated maximal possible amount of tetraploid cells (Table 2 ). This value is overestimated due to counting in diploid cells in the G2/M phase. Nocodazole arrests both suspension and adherent cells in the metaphase preventing spindle formation. By nocodozole-induced G2/M arrest, we estimated minimal amount of tetraploids and then compared both populations.
In NIH191-3 at both preneoplastic and neoplastic stages, the amounts of tetraploids estimated by serum starvation and nocodazole treatment were concordant, although at preneoplastic stage, % of cells with DNA population >4N was higher than >4N DNA population estimated by serum deprivation (Table 2 ). In NIH191-10 at preneoplastic stage, on contrary, the minimal possible amount of tetraploids determined by the nocodazole treatment grossly exceeded maximal determined by serum starvation (Table 2 ; Fig. 4 , panels II, III). It implies that at the preneoplastic stage, some NIH191-3 and at least 20% of NIH191-10 cells became polyploid by proceeding through new rounds of DNA synthesis without completing mitosis.
A period of genomic instability ended by formation of aneuploids with a normal diploid cell cycle. Tetraploid cells were significantly reduced in both clones; in the NIH191-10 clone they practically disappeared (Fig. 4C) . Chromosome instability and loss was reflected by the change in the DNA index from 1.67 for parental NIH 3T3 to 1.58 for both NIH191-3 and NIH191-10.
Tumorigenicity
Next, we evaluated the tumorigenic potential of stable HCV-core expressing NIH 3T3 cells in SCID mice using as a control malignant NIH 3T3 transformed by stable expression of HCV NS3 (as was described [52] ; NIHNS). IF staining and Western blot of the cells after a large scale culture done for to the mouse challenge, confirmed that NIH191-3 and 191-10 stably expressed HCV core, albeit at different levels (Fig. 1C, lanes 1  and 2) .
When inoculated into SCID mice, core-expressing NIH 3T3 clones rapidly generated solid tumors (Fig. 5) . NIH191-10 grew exponentially in all recipients of the high dose (100%) and in 75% recipients of the medium dose with a latency of 5 days (Fig. 5) . NIH191-3 inoculated at medium and high cell dose showed limited growth in totally 33% mice (Fig. 5) . Tumors appeared with the latency of 5 days and stopped growing by day 7 (Fig. 5) . NIHNS cells inoculated at medium and high dose demonstrated limited growth palpable as soft pads in all mice. They appeared by day 4, but started to recede by day 7 (Fig. 5) . Excised sites of inoculation of NIHNS cells were found to contain encapsulated cell suspensions, but no solid tumors. All in- NIH191-3 and NIH191-10-derived solid tumors consisted of collagen fiber fascicles interlaced in different directions, with connective elements to fibroblasts and fibrocytes (Fig. 6A,B) . The majority of cells had a spherical shape. Cell nuclei were polymorphic in size, form, and level of heterochromatization (Fig. 6 ). Cell polymorphism, increased prominent nucleoli and numerous scattered mitotic figures indicated a sarcomatous process. Some tumor areas were marked with dystrophic changes of cells (nuclear pyknosis, karyorrhexis, karyolysis). In these areas, the connective tissue component prevailed over the cellular one. Tumor outgrowths had numerous dilated capillaries, and in some areas, the sinusoid type vessels. The overall microscopic appearance indicated formation of spindle cell sarcomas (see www.usc.edu/hsc/dental/PTHL501/ SA/csa27.html). Tumors were stained by core-specific rabbit serum demonstrating that after inoculation into mice, cells continued to express HCV core (Fig. 7A-C) . This serum did not stain the area of encapsidation containing a suspension of NS3-expressing NI-HNS (Fig. 7D) . Tumors induced by NIH191-3 and NIH191-10 were not stained by the preimmune rabbit serum (Fig. 7E , and data not shown).
Influence of HCV core on the p53 transactivation
Genetic instability, resistance to apoptosis and tumorigenicity pointed at possible p53 dysfunction. To examine this, we investigated stored NIH191-3 and NIH191-10 clones that were used for tumor induction, for the status of the endogenous p53 transactivation. NIH 3T3 carries transcriptionally active wild-type p53 gene [16, 61] . Similarity between human and murine p53 and p53 responsive elements [50] permitted monitoring using the consensus p53 response element [11] . The p53 transactivation in NIH191-3 and NIH191-10 clones was decreased 5-to 10-fold (Fig. 8) . Similar effect was observed after transient transfection of the parental NIH 3T3 by a plasmid encoding amino acids 1 to 152 of HCV core. At the same time, transient expression of the full-length HCV core induced an increase in the endogenous p53 transactivation (Fig. 8) .
Discussion
The transforming ability of HCV core protein was so far considered as rather weak. It was tumorigenic in combinations with proto-oncogenes, or over-expressed , and by NIH191-10 at magnification ×40 (C), sections stained with core-specific polyclonal rabbit serum 34-6. Area of incapsidation containing suspension of control NIHNS cells stained with anti-core rabbit serum 34-6 at magnification ×40 (D). Solid tumor induced by NIH191-10 stained with the preimmune rabbit serum 34-0 at magnification ×20 (E). Fig. 8 . Transcriptional activation of p53 in the HCV core-expressing clones NIH191-3, and NIH191-10 as compared to the parental NIH 3T3 taken for 100%. To estimate the influence of HCV core on the endogenous p53, NIH191-3 and NIH191-10 were transfected with luciferase-expressing reporter plasmid pG13-luc, and parental NIH 3T3 were co-transfected with pG13-luc and pCMVcore191, or pCMVcore152.
cell cycle regulating proteins [59, 64] , but until recently was thought to be unable to completely transform cells and induce tumors [4, 21, 44] . Here, typical NIH 3T3 clones adapted for growth in the presence of HCV core were selected, and followed up longitudinally. We scrutinised cell physiology (growth, ploidy, sensitivity to apoptosis) during the establishment of NIH 3T3 that expressed HCV core constitutively, to see whether HCV core alone could promote cells to become cancerous.
During the establishment stage [34] , HCV core activity was first seen as the inhibition of NIH 3T3 cell growth. We have shown that the inhibition of cell growth by HCV core was accompanied by genomic instability. The earliest change in the cell ploidy was the appearance of tetraploid ( 4N) cells. While in the NIH191-3 clone, the tetraploid cells consisted of diploid ( 2N) and tetraploid ( 4N) subpopulations, in the NIH191-10 clone, the tetraploids appeared from the diploid cells as a result of the disrupted mitotic checkpoint. In the rat embryo fibroblast model of multistep oncogenesis, polyploidy serves as the initiator of neoplasm/tumor growth as the polyploid cells have an advantage over diploids in more efficient utilization of resources (albeit slow growth) [5] .
The ploidy shift was abrogated by genetic aberrations that accumulate during prolonged selection [13] .
Indeed, in the core-expressing NIH 3T3 at the stabilization stage, the tetraploids underwent a period of chromosome instability and DNA loss leading to a decreased DNA index identical for NIH191-3 and NIH191-10. Simultaneously with DNA loss, HCV core expressing NIH 3T3 clones acquired anchorage independence and absence of contact inhibition, the essential alterations determining malignancy [13] . The neoplastic/promotion stage of HCV core-induced transformation was characterized by yet another marker of malignant transformation -the suppression of apoptosis, observed also in the earlier studies [42, 45, 56] . In NIH191-10 clone with higher level of HCV core expression, genomic instability was attained through the disruption of mitotic spindle cell checkpoint, other mechanisms could be active in the NIH191-3 clone that expressed HCV core at a lower level. Interestingly, the effects of HCV core on the cell viability and p53-dependent transcription were also found to be concentration dependent [23, 42, 48] .
A pivotal genetic event in the loss of the control over the genomic instability and hepatocellular carcinogenesis is the p53 dysfunction [49, 60] . In concordance with the previously published data [46] , NIH 3T3 transformed by HCV core expression exhibited a 5-to 10-fold reduced p53 transactivation ability. This could have directly or indirectly promoted the neoplas-tic transformation. Inhibition of p53 transactivation in NIH 3T3 expressing core constitutively (and thus harbouring the processed C-terminus deleted HCV core [29, 39] ) was mimicked by transient transfection into NIH 3T3 of the gene encoding HCV core amino acids 1 to 152. Full-length unprocessed HCV core provided by transient transfection induced an increase in p53 transactivation (that may have been attained through transient core-induced increase in p53 expression [55] ). As it was recently demonstrated, HCV core targets the p53 pathway via three routes: physical interaction, post-translational p53 modification, and modulation of regulatory activity of p53 [23] . Notably, core can inhibit the p53-mediated apoptosis by blocking the interaction between p53 and ASPP2, a splicing version of Bcl2-binding protein that enhances the p53-induced apoptosis [3] . It can also rescue the p53-mediated suppression in both RNA polymerase I and III systems [23] . Core-induced reduction of p53 transactivation and its ability to relieve the p53-mediated suppression contribute to the loss of the control over the genomic instability and are consistent with the role of core in HCV-associated oncogenesis.
We finally evaluated the capacity of transformed NIH3T3 expressing HCV core to form solid tumors in the immunocompromised host. In SCID mice, syngenic cells/tumor cell lines/tumors are grafted with an average latency of 25 days (for C.B-17/SCID mice; [12] ), while allogenic grafts and tumors are rejected by the NK cells [35] . Numerous previous experiments have shown NIH 3T3 and NIH 3T3-derived Neo r -transfectants to be non-tumorigenic (see, for example, [25, 52, 57] ). Allogenic NS3-expressing NIHNS used here as a tumor-control were, on contrary, expected to induce tumors [52] . However, high-dose inoculates of NIHNS did not form solid tumors. The latter together with the rejection of all cell inoculates at a low dose, indicated potent NK cell activity. Despite this, cells expressing high levels of HCV core that underwent the mitotic spindle cell checkpoint disruption induced solid tumors in 88% of the recipients in only five days. The low-level core expressing cell line that at preneoplastic stage had basically kept undisrupted mitotic spindle cell check-point was weakly tumorigenic. Thus, constitutive HCV core expression turned NIH 3T3 into malignant cells.
Recently, constitutive expression of core was shown to completely transform the Chang-liver cells [53] . Transformation was registered by changes in cell morphology, increased proliferation rate seen as an increased proportion of cells in the S-phase, and varying DNA content. Injected into nude mice, coretransformed Chang-liver cells induced tumors that were morphologically typed as hepatocarcinomas [53] . Here, we made a step further describing both the events preceding and concomitant with transformation (preneoplastic and neoplastic stages), detailed changes in the DNA content as the increased ploidy followed by DNA loss, and depicted the disruption of the mitotic spindle cell checkpoint as the start-off of the transformation. Altogether, these data prove that HCV core alone is sufficient to induce malignant transformation of various cell types, and indicate that the pathway of this transformation seem to be shaped by the HCV core dose (expression level). Our results demonstrate that HCV core, with an accent on its processed form, acts by inducing first stress, and then stress release and unconditioned growth of core-expressing survivor cells through promotion of genomic instability and violation of the cell cycle checkpoints.
Core proteins derived from the tumor tissues possess multiple mutations and deletions [9, 15, 40, 51] and possibly different biological properties [9] . There are other indications that core variants differ in their effects on cellular signaling [9, 47] . For example, core of HCV 1b activated [8, 36, 63] , while core of HCV 1a suppressed nuclear factor kappaB (NF-κB) signaling [22, 47, 54] with differential regulation attributed to single amino acid polymorphisms [47] . HCV 1b core gene used here (AF176573) harbours some of the mutations associated with HCC, as G instead of S in position 45 [15] , and V in place of A at position 147 [40] , and aligns well with core sequences isolated from hepatocellular carcinomas (AB077722, AB077725, AB077728, AB077739, AB077743; [40] ). Also, it has crucial amino acids R9 and K11 involved in the activation of NF-κB signaling and consequent inhibition of apoptosis [47] . These may have contributed to the carcinogenicity of our HCV core variant. However, one should keep in mind that the capacity to interfere with cellular signalling had been repeatedly assigned to a multitude of core variants. Core of genotypes 1b, 2a, and 4d were shown to induce similar changes in the expression of genes involved in metabolism, signal transduction, protease activity, immune responses, and apoptosis [10] . We had completely transformed fibroblast cell line by constitutive expression of core of HCV 1b, while Shan Y. et al. achieved it by constitutive expression of core of HCV 2b [53] . Mice transgenic for HCV 1a core, E1 and E2 were also prone to liver and lymphoid tumor development [38] . Altogether, this indicates a basic role of HCV core in establishment and maintenance of neoplastic transformation.
We speculate here that versatile effects of HCV core on the host cells reflect general property of HCV core protein, and depend more on the levels of expression achieved, site of protein localization in the cell, cell type utilized, and the cellular environment than on a specific core sequence. This capacity of HCV core to induce cell re-programming is one of the tools used by hepatitis C virus for survival and propagation.
